Opioids remain the major medication for perioperative and chronic pain management, but their side effects, which include respiratory depression, constipation, addiction and others, relate to morbidity and mortality in our patients, as well as presenting a significant economic and political burden. Since both the analgesic and side effects are thought to arise from activation of the mu receptor (MUR), a better understanding of the structural and functional relationships of human MUR might provide clues for addressing this clinical dilemma. My long-term goal is to reveal the molecular recognition mechanism of opiates and opiate receptors by using biochemical, biophysical, protein engineering and the high resolution structural approaches. In this project, 4 specific aims are proposed.
In aim 1, we will establish a novel structural model of the human MUR from a combination of rhodopsin structural data and the newly available experimental structures of human ?2 adrenergic receptor. This will permit opioid and MUR interaction studies at the computational level.
In aim 2, we will engineer a variant of the water soluble, but structurally unaltered water soluble mu receptor (WSMUR) for dynamic opioid and receptor interactions in solution conditions.
In aim 3, we will express the WSMUR for biophysical characterization studies and for various binding studies with opioids in solution conditions.
In aim 4, we will crystallize the WSMUR for structural determinations in the presence or absence of opioids. As an anesthesiologist, formerly trained in academic centers in China, Japan, and United States, Dr. Liu is firmly committed to a career in academic anesthesia. His ultimate career goal is to achieve a better understanding of opioid and opioid receptor interactions, and use these data to develop optimal analgesics to ultimately improve patient care and satisfaction. This proposal will help him to reach his goals by providing further training and resources. His co-mentors have established records of nurturing junior faculty. Together with his current skill set, the advanced training enabled through the K-08 will help transition Dr. Liu towards an independent physician scientist in the area of perioperative medicine.
This project uses alternative structural approaches to investigate the relationship between opioids and human mu receptor. The information derived from this project may help to design novel opioid analgesics with minimal side effects, improve pain control, and solve issues related to opioids administration and abuse. Thus, this project has significant implications for public health.
|Ping, Jinglei; Xi, Jin; Saven, Jeffery G et al. (2017) Quantifying the effect of ionic screening with protein-decorated graphene transistors. Biosens Bioelectron 89:689-692|
|Chen, Stacey; Liu, Geoffrey L; Li, Marilyn M et al. (2017) Effects of Epinephrine on Inflammation-Related Gene Expressions in Cultured Rat Cardiomyocytes. Transl Perioper Pain Med 2:13-19|
|Jiang, Xueying; Orton, Margaret; Feng, Rui et al. (2017) Chronic Opioid Usage in Surgical Patients in a Large Academic Center. Ann Surg 265:722-727|
|Xi, Chunhua; Liang, Xuan; Chen, Chunhua et al. (2017) Hypoxia Induces Internalization of ?-Opioid Receptor. Anesthesiology 126:842-854|
|Zhu, Minmin; Yang, Zhengli; Liang, Xiao et al. (2016) Managerial Decision-making for Daily Case Allocation Scheduling and the Impact on Perioperative Quality Assurance. Transl Perioper Pain Med 1:20-30|
|Li, Wei; Sun, Huijiao; Chen, Hao et al. (2016) Major Depressive Disorder and Kappa Opioid Receptor Antagonists. Transl Perioper Pain Med 1:4-16|
|Zhao, Jing; Liu, Renyu (2016) Calling for a rapid recognition and response program for stroke in China. Transl Perioper Pain Med 1:1-4|
|Chen, Xiangdong; Ma, Wuhua; Liu, Renyu et al. (2016) The Development and Application of Airway Devices in China. Transl Perioper Pain Med 1:5-14|
|Naylor, Carl H; Kybert, Nicholas J; Schneier, Camilla et al. (2016) Scalable Production of Molybdenum Disulfide Based Biosensors. ACS Nano 10:6173-9|
|Wu, Fei-Xiang; He, Yan; Di, Hui-Ting et al. (2016) An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome. PLoS One 11:e0149877|
Showing the most recent 10 out of 47 publications